We report a patient with AHC and a de novo mutation in ATP1A3 at exon 18 (c.2443 g > A - p.Glu815Lys) who was treated with oral compounded ATP, which decreased the frequency and intensity of hemiplegic episodes. The gene discussed is ATP1A3; the disease is alternating hemiplegia of childhood.